Cost-effectiveness of sacituzumab govitecan versus chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer

• Main Authors: Jiao Xie (Author), SiNi Li (Author), YaMin Li (Author), JianHe Li (Author)
• פורמט: ספר
• יצא לאור: BMC, 2023-06-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Abstract Background The effectiveness of sacituzumab govitecan for metastatic triple-negative breast cancer (TNBC) has been reported in recent research, however, the value of the effectiveness and cost of sacituzumab govitecan is still unclear. Methods A microsimulation model was developed using dat...